Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Oxford Medical Products today announces additional three-month clinical trial results for Sirona, a weight-loss treatment targeting people who are overweight or have class I obesity (BMI 25-35) and ...

From singing on Broadway to playing beloved characters on the big screen (including everyone's favorite animated snowman, ...

Glp-1s cover a variety of drugs that are commonly used for weight loss, such as Ozempic, Wegovy and Mounjaro. And West ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours ... The price of GLP-1 drugs has attracted the scrutiny ...

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally ... to improve glycaemic control as an adjunct to diet and exercise, "providing patients with another option ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

By now, you likely know which foods and drinks can help prevent Type 2 diabetes—but did you know that the order in which you ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.